4 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow G & W Laboratories Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis Tazarotene Cream, 0.05%, Vehicle, Reference: Tazorac Cream, 0.05% - Plaque Psoriasis | Phase 3 | Completed | G & W Laboratories Inc. | 866 | 2014-05-01 | 2016-11-03 |
| Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris Vehicle, Tazarotene Cream, 0.1 %, Tazorac Cream, 0.1% - Acne Vulgaris | Phase 3 | Completed | G & W Laboratories Inc. | 1741 | 2014-05-01 | 2016-11-03 |
| Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids Anucort-HC, 25 Mg Rectal Suppository, Placebo suppository - Internal Hemorrhoids | Phase 2 | Completed | G & W Laboratories Inc. | 150 | 2013-10-01 | 2016-11-03 |
| Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing Human Immunodeficiency Virus Infection, Hepatitis C | Completed | G & W Laboratories Inc. | 1600 | 2011-08-01 | 2015-09-07 |
Acne Vulgaris (1) · Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Hepatitis C (1)
Exercise (1) · Hydrocortisone (1) · Suppositories (1) · tazarotene (1)
United States (4)
Michael Bukhalo, MD (2) · Allan G Coates, DO (1) · Niel Constantine, Ph.D. (1)